Major retrospective study reveals differences between invasive lobular cancer and invasive ductal cancer
Invasive Lobular Breast Cancer May Have Worse Prognosis than Ductal Cancer
Analysis of a multi-institutional cohort of patients with lobular breast cancer provides key insights into prognosis.
No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma
The combination of adjuvant chemotherapy and endocrine therapy is no more effective than endocrine therapy alone in improving survival outcomes in patients with early-stage invasive lobular breast cancer, Cleveland Clinic investigators have found.